Mobocertinib’s domestic availability and purchase channels

Mobocertinib is an oral targeted drug used to treat specific types of non-small cell lung cancer (NSCLC). It has been successfully launched in China, but its medical insurance approval is still in progress, so it has not yet been included in the scope of medical insurance reimbursement. If patients need to use mobosetinib, they can purchase it through a prescription issued by an oncologist in a regular hospital in China. However, due to the short time on the market, hospitals in some areas may not have fully distributed the product, so there are certain limitations in access channels. It is recommended that patients consult their attending doctor before use and confirm whether their hospital or pharmacy has a supply of medicines.

It is difficult to purchase moboxetinib in China, and some patients may encounter problems such as drug shortages or cumbersome procurement procedures. At this time, drugs can be obtained through legally qualified imported pharmacies or cross-border medical channels, but patients should be cautious when choosing channels and avoid purchasing through unknown channels to avoid buying fake or inferior drugs, which will affect the therapeutic effect and safety.

In overseas markets, mobosetinib has two options: original drug and generic drug. The original drugs are mainly the Hong Kong version of China and the Takeda version of Japan. The prices are relatively high, with the general price being about RMB 7,000 to 8,000 yuan per box. Since the quality and efficacy of original drugs are better guaranteed, many patients with better economic conditions will tend to choose original drugs as long-term treatment drugs.

In comparison, the price of generic drugs of mobosetinib is more affordable. Taking the Lao version of generic drugs as an example, its price is about 3,000 yuan, which is half or even lower than the price of the original drug. More importantly, generic drugs are basically the same as the original drugs in terms of drug ingredients and clinical efficacy, which can significantly reduce the financial burden on patients while ensuring efficacy. Therefore, generic drugs are also a viable option for price-sensitive patients who require long-term medication.

Reference link:https://www.drugs.com